Suppr超能文献

使用荟萃分析方法比较经导管缘对缘修复术与外科手术修复术治疗功能性二尖瓣反流患者的疗效。

Comparison of transcatheter edge-to-edge and surgical repair in patients with functional mitral regurgitation using a meta-analytic approach.

作者信息

Felbel D, Paukovitsch M, Förg R, Stephan T, Mayer B, Keßler M, Tadic M, Dahme T, Rottbauer W, Markovic S, Schneider L

机构信息

Department of Cardiology, Angiology, Pneumology and Intensive Care, University Hospital Ulm, Ulm, Germany.

Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.

出版信息

Front Cardiovasc Med. 2023 Jan 25;9:1063070. doi: 10.3389/fcvm.2022.1063070. eCollection 2022.

Abstract

BACKGROUND

Evidence regarding favorable treatment of patients with functional mitral regurgitation (FMR) using transcatheter edge-to-edge repair (TEER) is constantly growing. However, there is only few data directly comparing TEER and surgical mitral valve repair (SMVr).

AIMS

To compare baseline characteristics, short-term and 1-year outcomes in FMR patients undergoing mitral valve (MV) TEER or SMVr using a meta-analytic approach.

METHODS

Systematic database search identified 1,703 studies reporting on TEER or SMVr for treatment of FMR between January 2010 and December 2020. A meta-analytic approach was used to compare outcomes from single-arm and randomized studies based on measures by means of their corresponding 95% confidence intervals (CI). Statistical significance was assumed if CIs did not overlap. A total of 21 TEER and 37 SMVr studies comprising 4,304 and 3,983 patients were included.

RESULTS

Patients in the TEER cohort presented with higher age (72.0 ± 1.7 vs. 64.7 ± 4.7 years, < 0.001), greater burden of comorbidities like hypertension ( < 0.001), atrial fibrillation ( < 0.001), lung disease ( < 0.001) and chronic renal disease ( = 0.005) as well as poorer left ventricular ejection fraction (30.9 ± 5.7 vs. 36.6 ± 5.3%, < 0.001). In-hospital mortality was significantly lower with TEER [3% (95%-CI 0.02-0.03) vs. 5% (95%-CI 0.04-0.07)] and 1-year mortality did not differ significantly [18% (95%-CI 0.15-0.21) vs. 11% (0.07-0.18)]. NYHA [1.06 (95%-CI 0.87-1.26) vs. 1.15 (0.74-1.56)] and MR reduction [1.74 (95%-CI 1.52-1.97) vs. 2.08 (1.57-2.59)] were comparable between both cohorts.

CONCLUSION

Despite considerably higher age and comorbidity burden, in-hospital mortality was significantly lower in FMR patients treated with TEER, whereas a tendency toward increased 1-year mortality was observed in this high-risk population. In terms of functional status and MR grade reduction, comparable 1-year results were achieved.

摘要

背景

关于经导管缘对缘修复术(TEER)治疗功能性二尖瓣反流(FMR)患者的有利证据不断增加。然而,直接比较TEER和外科二尖瓣修复术(SMVr)的数据很少。

目的

采用荟萃分析方法比较接受二尖瓣(MV)TEER或SMVr的FMR患者的基线特征、短期和1年结局。

方法

系统数据库检索确定了1703项关于2010年1月至2020年12月期间TEER或SMVr治疗FMR的研究。采用荟萃分析方法,根据单臂研究和随机研究的测量结果及其相应的95%置信区间(CI)比较结果。如果CI不重叠,则认为具有统计学意义。总共纳入了21项TEER研究和37项SMVr研究,分别包含4304例和3983例患者。

结果

TEER队列中的患者年龄较大(72.0±1.7岁对64.7±4.7岁,P<0.001),合并症负担更重,如高血压(P<0.001)、心房颤动(P<0.001)、肺部疾病(P<0.001)和慢性肾病(P=0.005),左心室射血分数也更低(30.9±5.7%对36.6±5.3%,P<0.001)。TEER组的住院死亡率显著更低[3%(95%-CI 0.02-0.03)对5%(95%-CI 0.04-0.07)],1年死亡率无显著差异[18%(95%-CI 0.15-0.21)对11%(0.07-0.18)]。两组的纽约心脏协会(NYHA)功能分级[1.06(95%-CI 0.87-1.26)对1.15(0.74-1.56)]和二尖瓣反流(MR)减轻程度[1.74(95%-CI 1.52-1.97)对2.08(1.57-2.59)]相当。

结论

尽管TEER治疗的FMR患者年龄和合并症负担明显更高,但其住院死亡率显著更低,而在这一高危人群中观察到1年死亡率有增加趋势。在功能状态和MR分级降低方面,两组1年结果相当。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验